The use of FEIBA for surgery in patients with haemophilia and inhibitors

Haemophilia

Volumn 12, Issue SUPPL. 5, 2006, Pages 20-25

  Kraut, Eric H ^a  

^a OHIO STATE UNIVERSITY   (United States)

Author keywords

FEIBA; Haemophilia; Inhibitor; Surgery

Indexed keywords

ACTIVATED PROTHROMBIN COMPLEX; ALLOANTIBODY; AMINOCAPROIC ACID; AUTOANTIBODY; BLOOD CLOTTING FACTOR 8; FEIBA VH; RECOMBINANT BLOOD CLOTTING FACTOR 7A;

ANTIBODY TITER; ARTICLE; BLEEDING; BLOOD TRANSFUSION; DENTAL SURGERY; DRUG CONTRAINDICATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; DRUG MONITORING; DRUG SAFETY; DRUG TREATMENT FAILURE; FRANCE; HEART INFARCTION; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEMOSTASIS; HUMAN; IMMUNOLOGICAL TOLERANCE; LABORATORY TEST; MAJOR SURGERY; MEDICAL DECISION MAKING; MINOR SURGERY; NORWAY; PATIENT SAFETY; PERIOPERATIVE PERIOD; PEROPERATIVE COMPLICATION; POSTMARKETING SURVEILLANCE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; SPAIN; SURGICAL PATIENT; THROMBIN TIME; THROMBOEMBOLISM; THROMBOSIS; TREATMENT DURATION; UNITED STATES;

EID: 33750421926     PISSN: 13518216     EISSN: 13652516     Source Type: Journal    
DOI: 10.1111/j.1365-2516.2006.01381.x     Document Type: Article

References (21)

1. Rodriguez-Merchan EC, Wiedel JD, Wallny T et al. Elective orthopaedic surgery for inhibitor patients. Haemophilia 2003; 9: 625-31.
2. Rodriguez-Merchan EC, Rocino A. Literature review of surgery management in inhibitor patients. Haemophilia 2004; 10: 22-9.
3. Quintana-Molina M, Martinez-Bahamonde F, Gonzalez-Garcia E et al. Surgery in haemophilic patients with inhibitor: 20 years of experience. Haemophilia 2004; 10: 30-40.
4. Goddard N. Case studies: Orthopaedic surgery in adult patients with haemophilia A with inhibitors. Haemophilia 2005; 11: 32-7.
5. Shapiro AD, Gilchrist GS, Hoots WK, Cooper HA, Gastineau DA. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery. Thromb Haemost 1998; 80: 773-8.
6. Leissinger CA. Prevention of bleeds in hemophilia patients with inhibitors: Emerging data and clinical direction. Am J Hematol 2004; 77: 187-93.
7. DiMichele D, Negrier C. A retrospective postlicensure survey of FEIBA efficacy and safety. Haemophilia 2006; 12: 352-62.
8. Goudemand J, Tagariello G, Lopaciuk F. Cases of surgery in high-responder haemophilia patients. Haemophilia 2004; 10: 46-9.
9. Hilgartner M, Aledort L, Andes A, Gill J, the FEIBA Study Group. Efficacy and safety of vapor-heated anti-inhibitor coagulant complex in hemophilia patients. Transfusion 1990; 30: 626-30.
10. Negrier C, Goudemand J, Sultan Y, Bertrand M, Rothschild C, Lauroua P, the French FEIBA Study Group. Multicenter retrospective study on the utilization of FEIBA in France in patients with factor VIII and factor IX inhibitors. Thromb Haemost 1997; 77: 1113-9.
11. Tjonnfjord GE. Activated prothrombin complex concentrate (FEIBA) treatment during surgery in patients with inhibitors to FVIII/IX: The updated Norwegian experience. Haemophilia 2004; 10: 41-5.
12. Rodriguez-Merchan EC, Rocino A, Ewenstein B et al. Consensus perspectives on surgery in haemophilia patients with inhibitors: Summary statement. Haemophilia 2004; 10: 50-2.
13. FEIBA VH [package insert]. Westlake Village, CA: Baxter Healthcare Corporation, 2000.
14. Ehrlich HJ, Henzl MJ, Gomperts ED. Safety of factor VIII inhibitor bypass activity (FEIBA): 10-year compilation of thrombotic adverse events. Haemophilia 2002; 8: 83-90.
15. Kraut EH, Jordan S, Witkoff L, Stanek M. Control of bleeding in patients with inhibitors to factor VIII and IX undergoing surgical procedures. Poster presented at: XXVI International Congress of the World Federation of Hemophilia; October 17-21, 2004; Bangkok, Thailand.
16. Stine KC, Shrum D, Becton DL. Use of FEIBA for surgical procedures in patients with severe hemophilia A and inhibitors. Poster presented at: XXVI International Congress of the World Federation of Hemophilia; October 17-21, 2004; Bangkok, Thailand.
17. Aledort L. Inhibitors in hemophilia patients: Current status and management. Am J Hematol 1994; 47: 208-17.
18. Varadi K, Turecek PL, Schwarz HP. Thrombin generation assay and other universal tests for monitoring haemophilia therapy. Haemophilia 2004; 10: 17-21.
19. Dargaud Y, Lienhart A, Meunier S et al. Major surgery in a severe haemophilia A patient with high titre inhibitor: Use of the thrombin generation test in the therapeutic decision. Haemophilia 2005; 11: 552-8.
20. Ho AY, Height SE, Smith MP. Immune tolerance therapy for haemophilia. Drugs 2000; 60: 547-54.
21. Hayashi T, Tanaka I, Shima M et al. Unresponsiveness to factor VIII inhibitor bypassing agents during haemostatic treatment for life-threatening massive bleeding in a patient with haemophilia A and a high responding inhibitor. Haemophilia 2004; 10: 397-400.